Anzeige
Mehr »
Dienstag, 22.07.2025 - Börsentäglich über 12.000 News
Alarm am Metallmarkt: Kupfer unter Strom: USA rüsten sich - was das für Anleger bedeutet
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N5RL | ISIN: AU0000023822 | Ticker-Symbol:
Branche
Pharma
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
AMPLIA THERAPEUTICS LIMITED Chart 1 Jahr
5-Tage-Chart
AMPLIA THERAPEUTICS LIMITED 5-Tage-Chart

Aktuelle News zur AMPLIA THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoAMPLIA THERAPEUTICS LIMITED: Trading Halt-
11.07.AMPLIA THERAPEUTICS LIMITED: Another Partial Response in ACCENT Pancreatic Cancer Trial-
AMPLIA THERAPEUTICS Aktie jetzt für 0€ handeln
04.07.AMPLIA THERAPEUTICS LIMITED: Application for quotation of securities - ATX-
03.07.ASX June Health Winners: Sector falls 1.05pc but Amplia up 300pc after positive trial news1
02.07.AMPLIA THERAPEUTICS LIMITED: Annual General Meeting to be held Wednesday 27 August 2025-
02.07.AMPLIA THERAPEUTICS LIMITED: Additional Partial Response in Pancreatic Cancer Trial-
23.06.AMPLIA THERAPEUTICS LIMITED: Amplia Gains US Ethics Approval for Pancreatic Cancer Trial-
20.06.Hot Stocks: Santos, Tourism Holdings, ASX, Amplia5
19.06.Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 192
19.06.Amplia Therapeutics achieves second complete response with narmafotinib in pancreatic cancer trial1
19.06.Top 10 at 11: ASX dips in early trade; Amplia achieves second pancreatic cancer complete response1
19.06.Hot Stocks: KMD Brands, HomeCo Daily Needs REIT, Amplia Therapeutics1
19.06.AMPLIA THERAPEUTICS LIMITED: Change in substantial holding-
18.06.AMPLIA THERAPEUTICS LIMITED: Second Complete Response in ACCENT Pancreatic Cancer Trial-
16.06.Amplia Therapeutics Ltd: Pathological Complete Response Recorded In Patient From Accent Cancer Trial230HIGHLIGHTS A confirmed pathological complete response has been recorded in the ACCENT trial A pathological complete response (pCR) is extremely rare in patients...
► Artikel lesen
16.06.Amplia Therapeutics reports first pathological complete response in ACCENT pancreatic cancer trial1
16.06.Health Check: A pancreatic cancer 'cure' has been elusive, but Amplia may have cracked the nut1
16.05.Hot Stocks: Peak Rare Earths, Amplia, Immutep, Webjet, Aristocrat Leisure5
15.05.Amplia pops 40% on liquidity surge as chemo combo proves successful5
15.05.Health Check: Amplia shares surge on pancreatic cancer trial results; Immutep offers hope9
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1